POLYMORPHIC AND AMORPHOUS FORMS OF 2,5-DIMETHYL-2H-PYRAZOLE-3-CARBOXYLIC ACID {2-FLUORO-5-[3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDASOL-6-YLAMINO]-PHENYL}-AMIDE
The invention provides several polymorphic forms and an amorphous form of 2,5-Dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6ylamino]-phenyl}-amide, pharmaceutical compositions containing such polymorphic or amorphous forms, and methods of using such p...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
29.09.2005
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides several polymorphic forms and an amorphous form of 2,5-Dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6ylamino]-phenyl}-amide, pharmaceutical compositions containing such polymorphic or amorphous forms, and methods of using such pharmaceutical compositions to treat disease states mediated by protein kinases, such as cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation.
L'invention concerne plusieurs formes polymorphes et une forme amorphe de 2,5-diméthyle-2H-pyrazole-3-acide carboxylique {2-fluoro-5-[3-((E)-2-pyridine-2-yle-vinyle)-1H-indazole-6-ylamino]-phényle}-amide, des compositions pharmaceutiques contenant ces formes polymorphes ou amorphes, et des méthodes d'utilisation de ces compositions pharmaceutiques pour traiter des maladies dues à des protéines kinases telles que le cancer, et d'autres états pathologiques associés à l'angiogénèse et/ou à la prolifération cellulaire indésirables. |
---|---|
Bibliography: | Application Number: WO2005IB00616 |